[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Generic_Tina Tina Banerjee Tina Banerjee posts on X about japan, $4503t, canada, $4506t the most. They currently have XX followers and XXX posts still getting attention that total X engagements in the last XX hours. ### Engagements: X [#](/creator/twitter::1511682976639119365/interactions)  - X Week XXX +70% - X Month XXX -XXXX% - X Months XXXXX +100% - X Year XXXXXX +304% ### Mentions: X [#](/creator/twitter::1511682976639119365/posts_active)  - X Week XX +50% - X Month XX -XX% - X Months XXX +55% - X Year XXX +251% ### Followers: XX [#](/creator/twitter::1511682976639119365/followers)  - X Week XX no change - X Month XX -XXXX% - X Months XX +26% ### CreatorRank: undefined [#](/creator/twitter::1511682976639119365/influencer_rank)  ### Social Influence [#](/creator/twitter::1511682976639119365/influence) --- **Social category influence** [countries](/list/countries) XXXX% [finance](/list/finance) XXXX% [travel destinations](/list/travel-destinations) XXXX% **Social topic influence** [japan](/topic/japan) 1.16%, [$4503t](/topic/$4503t) 0.58%, [canada](/topic/canada) 0.58%, [$4506t](/topic/$4506t) 0.58%, [$8053t](/topic/$8053t) 0.58%, [novo](/topic/novo) 0.58%, [knight](/topic/knight) 0.58%, [hong kong](/topic/hong-kong) 0.58%, [ipo](/topic/ipo) 0.58%, [china](/topic/china) XXXX% **Top accounts mentioned or mentioned by** [@smartkarma](/creator/undefined) ### Top Social Posts [#](/creator/twitter::1511682976639119365/posts) --- Top posts by engagements in the last XX hours "Astellas Pharma's Izervay receives conditional approval in Japan for age-related macular degeneration. Izervay witnessed record high sales in Q1FY26 and a revenue growth of XX% is expected for FY26" [X Link](https://x.com/Generic_Tina/status/1973909683137282450) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-03T00:35Z XX followers, XX engagements "Sumitomo Pharma partners with Knight Therapeutics for exclusive licensing agreements in Canada and with Novo Nordisk in Japan for co-promotion of Ozempic leading to positive stock performance" [X Link](https://x.com/Generic_Tina/status/1978661813551239638) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-16T03:18Z XX followers, XX engagements "Top Glove Corp's revenue grew XX% YoY to RM 3.5B in FY25 driven by a XX% increase in sales volume amid competitive pricing. Positive outlook on stock as margin improved alongside volume growth" [X Link](https://x.com/Generic_Tina/status/1978983108612624775) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-17T00:35Z XX followers, XX engagements "Hansoh and Leads Biolabs bag global outlicensing deals. Chugais partner Lilly announced positive P3 result for orforglipron. Celltrion launched Actemra biosimilar in US" [X Link](https://x.com/Generic_Tina/status/1979707871999983865) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-19T00:35Z XX followers, XX engagements "Hansoh granted Roche exclusive license for CDH17-targeting ADC HS-20110. CDH17 targeted drug development scene is crowded. Hansohs strong execution with Roches global prowess will give it an edge" [X Link](https://x.com/Generic_Tina/status/1980070267860009308) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-20T00:35Z XX followers, XX engagements "Bama Tea (BAMA HK) launched Hong Kong IPO. Bama specializes in tea leaf products in China. Pure volume play with branded offerings in a fragmented market. We would recommend to subscribe the issue" [X Link](https://x.com/Generic_Tina/status/1980432680786489760) [@Generic_Tina](/creator/x/Generic_Tina) 2025-10-21T00:35Z XX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Tina Banerjee posts on X about japan, $4503t, canada, $4506t the most. They currently have XX followers and XXX posts still getting attention that total X engagements in the last XX hours.
Social category influence countries XXXX% finance XXXX% travel destinations XXXX%
Social topic influence japan 1.16%, $4503t 0.58%, canada 0.58%, $4506t 0.58%, $8053t 0.58%, novo 0.58%, knight 0.58%, hong kong 0.58%, ipo 0.58%, china XXXX%
Top accounts mentioned or mentioned by @smartkarma
Top posts by engagements in the last XX hours
"Astellas Pharma's Izervay receives conditional approval in Japan for age-related macular degeneration. Izervay witnessed record high sales in Q1FY26 and a revenue growth of XX% is expected for FY26"
X Link @Generic_Tina 2025-10-03T00:35Z XX followers, XX engagements
"Sumitomo Pharma partners with Knight Therapeutics for exclusive licensing agreements in Canada and with Novo Nordisk in Japan for co-promotion of Ozempic leading to positive stock performance"
X Link @Generic_Tina 2025-10-16T03:18Z XX followers, XX engagements
"Top Glove Corp's revenue grew XX% YoY to RM 3.5B in FY25 driven by a XX% increase in sales volume amid competitive pricing. Positive outlook on stock as margin improved alongside volume growth"
X Link @Generic_Tina 2025-10-17T00:35Z XX followers, XX engagements
"Hansoh and Leads Biolabs bag global outlicensing deals. Chugais partner Lilly announced positive P3 result for orforglipron. Celltrion launched Actemra biosimilar in US"
X Link @Generic_Tina 2025-10-19T00:35Z XX followers, XX engagements
"Hansoh granted Roche exclusive license for CDH17-targeting ADC HS-20110. CDH17 targeted drug development scene is crowded. Hansohs strong execution with Roches global prowess will give it an edge"
X Link @Generic_Tina 2025-10-20T00:35Z XX followers, XX engagements
"Bama Tea (BAMA HK) launched Hong Kong IPO. Bama specializes in tea leaf products in China. Pure volume play with branded offerings in a fragmented market. We would recommend to subscribe the issue"
X Link @Generic_Tina 2025-10-21T00:35Z XX followers, XX engagements
/creator/twitter::Generic_Tina